Yungshin Global Holding Corp operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Yungshin Global Holding Corp with three other
companies in this sector in Taiwan:
Lotus Pharmaceutical Co.,Ltd.
(2017
sales of 6.42 billion Taiwanese Dollars [US$208.00 million]
of which 90%
was Western Medicine Manufacture),
China Chemical and Pharmaceutical Company Limited
(6.24 billion Taiwanese Dollars [US$202.21 million]
of which 72%
was Taiwan), and
Pharmally International Holding Company Ltd
(4.30 billion Taiwanese Dollars [US$139.38 million]
of which 42%
was Glass Bottle).

Sales Analysis.
Yungshin Global Holding Corp reported sales of 6.62 billion Taiwanese Dollars (US$214.44 million)
for the
year ending
December of 2017.
This
represents
an
increase of 7.0%
versus 2016, when the company's sales were 6.19 billion Taiwanese Dollars.
Sales at Yungshin Global Holding Corp have increased during each of the previous five years
(and since 2012, sales have increased a total of 41%).
Sales of American District saw an increase
that was more than double the company's growth rate: sales were up
79.0% in 2017, from
295.09 million Taiwanese Dollars to 528.13 million Taiwanese Dollars.
Not all segments of Yungshin Global Holding Corp experienced an increase in sales in 2017:
sales of Japanese District fell 11.6% to 639.96 million Taiwanese Dollars.